Valuation : Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.58B 1.13B 971M 910M 831M 1.57B 108B 1.57B 10.8B 4.21B 54.36B 4.23B 4.14B 180B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.09B 756M 652M 611M 558M 1.05B 72.28B 1.05B 7.25B 2.83B 36.49B 2.84B 2.78B 121B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-2.04%
1 week-0.46%
Current month-3.99%
1 month-4.98%
3 months-0.76%
6 months-5.53%
Current year-12.12%
1 week 12.75
Extreme 12.75
13.48
1 month 12.75
Extreme 12.75
13.93
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
16
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 07/01/2019
Director of Finance/CFO 49 06/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24 Buy 500 0.0001%
22/01/20 Sell

Director

246,300 0.0462%
01/01/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%-0.46%-18.82%-44.67% 1.13B
+0.02%+1.36%-13.16%-7.68% 13.26B
+0.53%+2.99%-31.39%-55.80% 4.99B
+0.27%+1.59%-5.32%-4.34% 4.66B
-0.43%-1.64%-1.22%-30.17% 4.02B
+0.08%+3.06%-20.99%+4.77% 3.59B
-0.67%+2.71%-2.98%-4.10% 3.43B
+0.47%-0.53%-9.87%+7.51% 3.31B
-2.19%-2.26%-22.25%-13.02% 2.38B
+0.74%+2.97%-26.78%-14.44% 1.72B
Average -0.32%+1.81%-15.28%-16.19% 4.25B
Weighted average by Cap. -0.10%+1.71%-14.11%-14.12%

Financials

2024 2025
Net sales 3.38B 502M 433M 406M 370M 697M 47.97B 700M 4.81B 1.88B 24.22B 1.88B 1.84B 80.3B 2.32B 345M 297M 278M 254M 479M 32.93B 480M 3.3B 1.29B 16.62B 1.29B 1.27B 55.11B
Net income 492M 73.13M 63.02M 59.09M 53.94M 102M 6.99B 102M 701M 274M 3.53B 275M 269M 11.7B -258M -38.32M -33.02M -30.96M -28.26M -53.24M -3.66B -53.41M -367M -143M -1.85B -144M -141M -6.13B
Net Debt -2.29B -340M -293M -275M -251M -473M -32.52B -474M -3.26B -1.27B -16.42B -1.28B -1.25B -54.44B -2.49B -370M -319M -299M -273M -515M -35.4B -516M -3.55B -1.39B -17.87B -1.39B -1.36B -59.26B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
28/08/26 CN¥12.98 -2.04% 4,714,400
27/08/26 CN¥13.25 +0.23% 4,390,800
26/08/26 CN¥13.22 -0.23% 4,346,464
25/08/26 CN¥13.25 +3.03% 4,538,451
24/08/26 CN¥12.86 -1.38% 5,097,781

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock